ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,582Medicare Part D Prescriptions Filled, Including Refills

Rank: 202 out of 625

$427K Total Retail Price of All Prescriptions

Rank: 237 out of 625

455 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 455 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 455 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 6,541 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
SIMVASTATIN 272 245 1 2
HYDROCODONE-ACETAMINOPHEN 270 171 S3 2 4
AMLODIPINE BESYLATE 247 245 3 1
OMEPRAZOLE 240 192 4 6
LEVOTHYROXINE SODIUM 225 181 5 3
ATORVASTATIN CALCIUM 221 195 6 9
ZOLPIDEM TARTRATE 209 177 7 13
SYNTHROID 146 138 8 39
LISINOPRIL 146 137 8 5
FUROSEMIDE 136 118 10 7
CITALOPRAM HBR 125 113 11 24
POTASSIUM CHLORIDE 124 96 12 19
HYDROCHLOROTHIAZIDE 123 119 13 12
BENAZEPRIL HCL 121 115 14 35
LOSARTAN POTASSIUM 108 93 15 18
SERTRALINE HCL 108 95 15 26
PRAVASTATIN SODIUM 102 82 17 8
METOPROLOL SUCCINATE 98 98 18 15
FLUTICASONE PROPIONATE 95 75 19 32
DIOVAN 95 82 19 28
AZITHROMYCIN 90 76 21 40
METFORMIN HCL 76 55 22 10
PANTOPRAZOLE SODIUM 75 75 23 44
METOPROLOL TARTRATE 72 72 24 11
MELOXICAM 72 70 24 31
CARVEDILOL 70 66 26 23
GABAPENTIN 68 48 27 14
TAMSULOSIN HCL 68 68 27 36
CIPROFLOXACIN HCL 67 63 29 60
DIOVAN HCT 67 62 29 52
WARFARIN SODIUM 66 66 31 20
EVISTA 61 61 32 130
ROPINIROLE HCL 60 60 33 96
NEXIUM 59 35 34 21
DONEPEZIL HCL 58 58 35 33
ZETIA 54 54 36 66
METFORMIN HCL ER 53 48 37 41
ATENOLOL 52 51 38 22
PREMARIN 52 39 R 38 105
GLIMEPIRIDE 50 50 40 42
AMLODIPINE BESYLATE-BENAZEPRIL 50 26 40 48
RAMIPRIL 50 50 40 78
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 17, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.